Clinical studies recruiting near Leeds

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · St James's University Hospital ( Site 3004) · Merck Sharp & Dohme LLC · NCT06136559 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · St James's University Hospital-Leeds Cancer Centre ( Site 26 · Merck Sharp & Dohme LLC · NCT06393374 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6404 · Galderma R&D · NCT06988605 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · Research Site · AstraZeneca · NCT07509151 Methods of T Cell Depletion Trial (MoTD)
Phase 2 · St Jame's University Hospital · University of Birmingham · NCT04888741 A First-in-human Dose Escalation and Expansion Study to Evaluate the Safety, and Tolerability of AZD8421 Alone or in Com
Phase 1/Phase 2 · Research Site · AstraZeneca · NCT06188520 The Oxford Risk Factors And Non-Invasive Imaging Study
Phase N/A · Leeds Teaching Hospitals NHS Trust · University of Oxford · NCT05169333 Impact of Chronic Cough on Activities of Daily Living and Response to Acute High-intensity Exercise
Phase N/A · University of Leeds · University of Leeds · NCT06766175 Comparison of EVAR and ESAR for Infrarenal Aortic Aneurysms With a Wide Proximal Neck
NA · Leeds General Infirmary · Rijnstate Hospital · NCT05484115 A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · St James's University Hospital, Leeds Haemophilia Centre · Hemab ApS · NCT06754852 A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Phase 2 · Research Site · AstraZeneca · NCT07276581 A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child
Phase 3 · Leeds Teaching Hospitals NHS Trust | Leeds Children's Hospit · Bayer · NCT07192952 Pembrolizumab With Olaparib as Combined Therapy in Metastatic Pancreatic Cancer
Phase 2 · St James' University Hospital · Cambridge University Hospitals NHS Foundation Trust · NCT05093231 A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in
Phase N/A · Leeds Teaching Hosp NHS Trust · Hoffmann-La Roche · NCT07284121 A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced
Phase 1/Phase 2 · St James´s University Hospital · BioNTech SE · NCT07186842 Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Seve
Phase N/A · Leeds General Infirmary · Esteve Pharmaceuticals, S.A. · NCT00903110 Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Phase 3 · St James's University Hospital - PPDS · Gilead Sciences · NCT06051617 Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies
Phase 1 · St James's University Hospital · Exscientia AI Ltd., a wholly owned subsidiary of Recursion P · NCT06980116 Understanding Inflammation, InFection and Interventions in Severe Exacerbations of Cystic Fibrosis
Phase N/A · Leeds Adult CF Centre · Alexander Horsley · NCT07484607 Probiotic Impact on Cognitive Performance, and Metabolic Outcomes in Overweight Young Adults With Impaired Glucose Regul
NA · Leeds Beckett University · Leeds Beckett University · NCT07073781 Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC)
Phase 2 · St James's Hospital · University College, London · NCT05185739 A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes
Phase N/A · Leeds General Infirmary · Bristol-Myers Squibb · NCT05489705 Duroplasty for Injured Cervical Spinal Cord With Uncontrolled Swelling
NA · Leeds General Infirmary · St George's, University of London · NCT04936620 HOPE Against Cancer Recurrence in HCC
Phase 4 · Leeds Teaching Hospitals NHS Trust · Philipp Dutkowski · NCT06717919 An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Au
Phase N/A · Leeds Teaching Hospitals NHS Trust · Splice Bio · NCT06435000 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · St James University Hospital ( Site 2055) · Merck Sharp & Dohme LLC · NCT06623422 Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesop
Phase 3 · St James's University Hospital · Daiichi Sankyo · NCT06731478 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · St James's University Hospital · Takeda · NCT06499285 Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of
Phase 3 · Research Site · AstraZeneca · NCT06921785 High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)
Phase 3 · Leeds General Infirmary · Gustave Roussy, Cancer Campus, Grand Paris · NCT04221035

Look up another city

Look up another condition